EyePoint, Inc. (EYPT)
4.875
-0.44
(-8.36%)
USD |
NASDAQ |
Aug 24, 16:00
4.89
+0.02
(+0.31%)
After-Hours: 20:00
EyePoint 1 Year Total Returns (Daily) : -54.14% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | -54.14% |
| August 20, 2026 | -53.08% |
| August 19, 2026 | -42.93% |
| August 18, 2026 | -51.72% |
| August 17, 2026 | -56.09% |
| August 14, 2026 | 35.94% |
| August 13, 2026 | 22.43% |
| August 12, 2026 | 25.86% |
| August 11, 2026 | 27.01% |
| August 10, 2026 | 27.76% |
| August 07, 2026 | 37.93% |
| August 06, 2026 | 21.27% |
| August 05, 2026 | 12.49% |
| August 04, 2026 | 16.00% |
| August 03, 2026 | 27.91% |
| July 31, 2026 | 24.75% |
| July 30, 2026 | 30.69% |
| July 29, 2026 | 21.02% |
| July 28, 2026 | 19.24% |
| July 27, 2026 | 18.42% |
| July 24, 2026 | 16.21% |
| July 23, 2026 | 16.54% |
| July 22, 2026 | 21.15% |
| July 21, 2026 | 23.81% |
| July 20, 2026 | 21.50% |
| Date | Value |
|---|---|
| July 17, 2026 | 29.13% |
| July 16, 2026 | 29.62% |
| July 15, 2026 | 40.75% |
| July 14, 2026 | 35.00% |
| July 13, 2026 | 37.84% |
| July 10, 2026 | 33.09% |
| July 09, 2026 | 35.40% |
| July 08, 2026 | 40.80% |
| July 07, 2026 | 47.73% |
| July 06, 2026 | 48.56% |
| July 02, 2026 | 44.72% |
| July 01, 2026 | 38.17% |
| June 30, 2026 | 51.97% |
| June 29, 2026 | 46.37% |
| June 26, 2026 | 31.73% |
| June 25, 2026 | 30.08% |
| June 24, 2026 | 56.86% |
| June 23, 2026 | 73.67% |
| June 22, 2026 | 63.06% |
| June 18, 2026 | 52.24% |
| June 17, 2026 | 49.26% |
| June 16, 2026 | 44.72% |
| June 15, 2026 | 33.78% |
| June 12, 2026 | 47.07% |
| June 11, 2026 | 41.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Ocular Therapeutix, Inc. | -8.66% |
| Eli Lilly & Co. | 77.98% |
| Elanco Animal Health, Inc. | 37.05% |
| Amylyx Pharmaceuticals, Inc. | 358.6% |
| Nuvation Bio, Inc. | 152.9% |